Broadwater Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$784 Sell
12
-41
-77% -$2.77K ﹤0.01% 201
2026
Q2
$3.39K Hold
53
– – ﹤0.01% 181
2026
Q1
$4.35K Hold
53
– – ﹤0.01% 179
2025
Q4
$4.35K Sell
53
-29
-35% -$2.26K ﹤0.01% 179
2025
Q3
$6.16K Sell
82
-5,992
-99% -$447K ﹤0.01% 175
2025
Q2
$6.07K Buy
6,074
+5,992
+7,307% +$417K ﹤0.01% 177
2025
Q1
$6.62K Sell
82
-45
-35% -$3.87K 0.01% 174
2024
Q4
$9.9K Hold
127
– – 0.01% 172
2024
Q3
$11.9K Hold
127
– – 0.01% 168
2024
Q2
$9.9K Hold
127
– – 0.01% 170
2024
Q1
$11.5K Hold
127
– – 0.01% 166
2023
Q4
$9.8K Buy
+127
New +$8.89K 0.01% 168

Other funds holding GEHC

Broadwater Capital's GEHC Position: Q3 2026 in Review

Broadwater Capital reduced its GE HealthCare (GEHC) stake by 77% in Q3 2026, selling an estimated $2.77K and leaving 12 shares worth $784. The position accounts for ﹤0.01% of the portfolio, ranked #201.

Broadwater Capital first reported a position in GEHC in Q4 2023 and has held it in 12 quarters since. The position peaked at $11.9K in Q3 2024. 907 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • Broadwater Capital held 12 shares of GE HealthCare worth $784 as of Q3 2026.
  • Broadwater Capital sold 41 GE HealthCare shares in Q3 2026, an estimated $2.77K.
  • GE HealthCare made up ﹤0.01% of Broadwater Capital's portfolio in Q3 2026, its #201 holding.
  • Broadwater Capital first reported a position in GE HealthCare in Q4 2023 and has held it in 12 quarters since.
  • Broadwater Capital's GE HealthCare position peaked at $11.9K in Q3 2024.
  • 907 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on Broadwater Capital's 13F filing for Q3 2026, filed 12 Nov 2026.